Last Updated: May 10, 2026

Suppliers and packagers for defencath


✉ Email this page to a colleague

« Back to Dashboard


defencath

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Cormedix DEFENCATH heparin sodium; taurolidine SOLUTION;N/A 214520 NDA CorMedix Inc. 72990-103-10 10 VIAL, SINGLE-DOSE in 1 CARTON (72990-103-10) / 3 mL in 1 VIAL, SINGLE-DOSE (72990-103-03) 2024-04-09
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies Defencath? A Contract-Manufacturing and Ownership Map

Last updated: April 27, 2026

What is Defencath and who supplies it?

“Defencath” is not a globally standardized INN/USAN brand name tied to one unambiguous, single-entity manufacturer in open public registries. In practice, “suppliers for Defencath” typically means one of two things in market workflows:

  • A contract manufacturer (CMO/CDMO) producing the finished drug product (FDF) or drug substance (API)
  • A trading supplier/distributor supplying hospitals/pharmacies with the finished product

Because public, regulator-linked sourcing data is not uniquely attributable to “Defencath” from the information provided, no complete and accurate supplier roster can be produced.

Can supplier identities be derived from patent or regulatory filings?

A defensible supplier mapping requires at least one of the following, each linked to a specific legal entity in filings:

  • a country-level marketing authorization holder (MAH)
  • an API or FDF applicant name from a regulator
  • labeling/manufacturer of record on packaging (SDS/PI/IFU)
  • assignee names in granted or pending patents that explicitly cover the product and identify production entities

None of these anchors are available in the prompt, so a supplier list would risk mixing unrelated products/brands or the wrong legal entities.

What can be stated about “Defencath” without introducing errors?

Nothing specific and complete can be stated about supplier identities (API manufacturer, finished-dose manufacturer, or distributor) in a way that stays accurate and business-usable. Producing a named supplier table without a verifiable anchor would create high risk of misattribution.


Key Takeaways

  • “Suppliers for Defencath” cannot be answered accurately with the current input because the product-to-legal-entity linkage is not specified.
  • Supplier mapping (API/CDMO/MAH/distributor) requires a regulatory or labeling anchor that identifies the responsible entities.
  • No factual supplier roster is provided to avoid misattribution.

FAQs

  1. What does “supplier” mean for a pharmaceutical brand like Defencath?
    It usually means API manufacturer, finished-dose contract manufacturer, marketing authorization holder, or distributor. Each has different evidentiary sources.

  2. How do I verify the real supplier for a drug product?
    Use the marketing authorization dossier/applicant and the “manufactured by” or “license holder” section on approved labeling/SDS.

  3. Can patents identify the drug manufacturer?
    Sometimes, but patent assignees often reflect R&D owners, not the manufacturing legal entity. Confirmation requires dossier or label evidence.

  4. Are distributor names the same as manufacturers?
    No. Distributors can change without changing the manufacturer of record.

  5. Why can’t a supplier list be produced from the brand name alone?
    Brand names can be region-specific or reused across markets, and supplier facts are stored in regulator-linked documents, not the brand name itself.


References

[1] No sources were used because no verifiable Defencath-to-entity linkage was provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.